Erratum
Authors:
- Markus LaimerMLMarkus Laimer
- Christoph F EbenbichlerCEChristoph F Ebenbichler
- Michael KranebitterMKMichael Kranebitter
- Ursula EderUEUrsula Eder
- Barbara MangwethBMBarbara Mangweth
- Elisabeth WeissEWElisabeth Weiss
- Alex HoferAHAlex Hofer
- Martina HummerMHMartina Hummer
- Georg KemmlerGKGeorg Kemmler
- Monika LechleitnerMLMonika Lechleitner
- Josef R PatschJPJosef R Patsch
- W Wolfgang FleischhackerWFW Wolfgang Fleischhacker
- 1 April 2005
- journal article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 25 (2) , 201
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Olanzapine Induces Insulin ResistanceThe Journal of Clinical Psychiatry, 2003
- Olanzapine‐Associated Diabetes MellitusPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- Hyperglycemic Clamp Assessment of Insulin Secretory Responses in Normal Subjects Treated with Olanzapine, Risperidone, or PlaceboThe Journal of Clinical Endocrinology & Metabolism, 2002
- Clozapine-associated diabetesThe American Journal of Medicine, 2001
- Different effects of antipsychotic drugs on insulin release in vitroEuropean Neuropsychopharmacology, 2001
- Association of Olanzapine-Induced Weight Gain With an Increase in Body FatAmerican Journal of Psychiatry, 2001
- Obesity and insulin resistanceJournal of Clinical Investigation, 2000
- Antipsychotic-Induced Weight Gain: A Comprehensive Research SynthesisAmerican Journal of Psychiatry, 1999
- Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in ObesityBiochemical and Biophysical Research Communications, 1999
- IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin ResistanceScience, 1996